Belief is a beautiful armor. But makes for the heaviest sword. Like punching underwater, you never can hit who you’re trying for.
~ John Mayer, “Belief”
It’s not the responsibility of the unvaccinated to protect the vaccinated, that’s the vaccine’s job.
Politicians and media, in lock-step, have claimed that the unvaccinated are the reason the COVID-19 pandemic is not ending, and because of them society cannot return to a normal way of living. Some governing authorities are taking this point-of-view one step further and advocating harsh punitive measures for anyone refusing to be vaccinated, based on this fabricated “pandemic of the unvaccinated.”
Does the foundation of immunology, epidemiology, and ethics, on which medical decisions have historically been made, support this? Does the 10+ months of data accumulated since COVID-19 vaccines were introduced validate the existence of a pandemic of the unvaccinated?
What does it mean to be immune and how does that relate to being vaccinated?
In order to answer these questions and fully grasp the magnitude of the faulty premises on which COVID-19 vaccine policy is being formulated, one needs to have a basic understanding of immunity and how it is achieved.
At a glance:
- Immunity is the body’s ability to resist infection by producing antibodies or a T-cell response after exposure to an infectious agent.
- Vaccines are substances which stimulate the production of an immune response without inducing the disease.
- Vaccination refers to the act of receiving a vaccine.
- Immunity developed to a pathogen subsequent to and as a direct result of receiving the vaccine, is referred to as immunization.
- Immunity is not synonymous with vaccination.
- COVID-19 vaccines have not been shown to result in immunization.
The Centers for Disease Control and Prevention (CDC) currently defines immunity, immunization, vaccine, and vaccination as follows:
Immunity: Protection against a disease. There are two types of immunity, passive and active. Immunity is indicated by the presence of antibodies in the blood and can usually be determined with a laboratory test (this CDC definition is also limited as it does not take into account T-cell mediated or mucosal IgA in the absence of readily detectable antibodies in blood).
Active Immunity: The production of antibodies or a specific T-cell mediated response against a pathogen by the immune system. Active immunity can be acquired in two ways, either by contracting the disease or through vaccination.
Passive Immunity: Protection against disease through antibodies produced by another human being or animal. Passive immunity is effective, but protection is generally limited and diminishes over time (usually a few weeks or months). For example, maternal antibodies are passed to the infant prior to birth. These antibodies temporarily protect the baby for the first 4-6 months of life.
Immunization: The process of being made immune or resistant to an infectious disease, typically by the administration of a vaccine. It implies that an immune response was elicited.
Vaccine: A preparation that is used to stimulate the body’s immune response against diseases. (historically defined as a suspension of live (usually attenuated) or inactivated microorganisms (e.g. bacteria or viruses) or fractions thereof administered to induce immunity and prevent infectious diseases and their sequelae, the CDC recently changed the definition of vaccines in order to accommodate mRNA and DNA therapeutics.)
Vaccination: The physical act of administering any vaccine or toxoid.
It is clear there are several ways to attain immunity, vaccinations are but one method. Thus the goal of one hundred percent vaccination is misguided. The objective should be to move as many people as possible into the immune group regardless of the route taken to immunity.
If a substantial number of people are already immune to the pathogen, the necessity to vaccinate is reduced. One example that showcases this is the Diamond Princess cruise ship. Data from the ship indicates that up to 80% of people have prior immunity from exposure to closely related Coronaviruses and thus only a small section of the population is at risk of serious illness from SARS-CoV-2, negating the need for vaccination in these individuals. Similarly, if a substantial number of people are immune due to sickness and recovery, the necessity to vaccinate is further reduced.
COVID-19 vaccines do not provide lasting, durable immunity, and in fact, the 6-month follow-up studies of Pfizer and Moderna vaccines show a minor increase in total mortality of the vaccinated group. CDC Director Rochelle Walensky stated in an interview, that “they [the vaccines] continue to work well for Delta, with regard to severe illness and death — they prevent it. But what they can’t do anymore is prevent transmission.” (Emphasis added.) Neither were the vaccines properly tested to determine if they produce this type of immunity. Initial studies, under which EUA was granted, explicitly stated the endpoint measures were PCR test positivity, accompanied by at least one from a list of COVID-19 symptoms.
Peter Hotez, Dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston, cited in “Will Covid-19 vaccines save lives? Current trials aren’t designed to tell us”, says:
Ideally, you want an antiviral vaccine to do two things . . . first, reduce the likelihood you will get severely ill and go to the hospital, and two, prevent infection and therefore interrupt disease transmission.
Peter Doshi, senior editor of the British Medical Journal and associate professor at the University of Maryland School of Pharmacy, adds:
Yet the current phase III trials are not actually set up to prove either. None of the trials currently underway are designed to detect a reduction in any serious outcome such as hospital admissions, use of intensive care, or deaths. Nor are the vaccines being studied to determine whether they can interrupt transmission of the virus.
Extract of Article: Read full Article: Source: PANDA